Five years on from Asia-Pacific’s venture capital surge, most startups funded at the peak remain in business, but far fewer have kept advancing through new rounds, later stages or exits. A PitchBook resaerch study published in late August 2026 tracks the 24,602 unique APAC-headquartered companies that raised venture money in 2020 or 2021 and examines what became of them by mid-2026.
The boom itself was enormous. In 2021 alone, investors poured $233.2 billion into 19,049 deals across the region.
Once interest rates rose, exits dried up and investors grew more selective, dealmaking fell sharply. Attention has since focused on the drop in new capital.
PitchBook instead asks what happened to the companies that received that capital.
Survival rates look robust. Of the full cohort, 82.8 percent are still operating as private companies.
Acquisitions or buyouts account for 5.7 percent, public listings for 4 percent, and bankruptcies or closures for only 7.5 percent.
High-profile collapses have occurred, yet outright failure across the group has been limited.
Continued venture progress has been rarer. Only 46.8 percent completed another venture round after 2021.
Roughly one in five raised two or more later rounds, and just 25.6 percent moved to a later financing stage than they occupied at the end of 2021.
Companies that did return typically raised only once more, with a median gap of 1.6 years before the next cheque.
Remaining solvent has therefore proved easier than repeatedly climbing the venture ladder.
Comparisons with earlier groups sharpen the picture.
PitchBook examined two-year cohorts from 2016-17 and 2018-19 over matching four-year windows.
The share securing at least one follow-on round stayed similar, around 48 percent.
Yet the 2020-21 group lagged on repeated fundraising (20.4 percent versus 24-26 percent), stage progression and exits (9.7 percent versus 13-15 percent).
Failure rates also declined across successive cohorts, from 15.7 percent to 7.5 percent, while the portion still active with no further recorded venture money rose to 40.3 percent.
Abundant capital during the boom may have given companies a longer runway to weather the subsequent drought, even as the bar for new investment rose and exit paths narrowed.
The longest pauses appear among the earliest-stage survivors.
Nearly 88 percent of still-active pre-seed or seed companies have not recorded a venture round in at least four years.
That figure drops to 70 percent at early-stage, 46 percent at late-stage and only 18 percent at growth stage. Some of these firms are not small.
India’s CoinSwitch, Indonesia’s Ajaib and Australia’s v2food each raised more than $100 million yet remain classified as early-stage with no venture activity since 2021.
High survival therefore coexists with a large backlog of companies that have simply stopped moving through the typical venture cycle.
Sector patterns vary. Consumer (B2C) firms show the weakest follow-on activity: 37.8 percent raised again and almost half remain private with no further venture money.
Healthcare performed best, with 56.4 percent raising again, stronger stage progression and only 3.9 percent failing.
Information technology, the largest group, sat in between.
The post-boom emphasis on unit economics and profitability hit capital-intensive consumer models especially hard, while healthcare benefited from structural demand and longer development cycles that still require private capital.
The research report’s conclusion is measured.
The boom did not produce a wave of failures, nor did it produce widespread maturation.
A sizable population of companies now sits between mere survival and genuine venture progress. Whether that backlog eventually resumes fundraising, finds exits or settles into more modest private lives will determine the boom’s longer-term legacy as APAC venture capital remains selective.